TABLE 1 LAMEA Biosimilars Market, 2018 - 2021, USD Million
TABLE 2 LAMEA Biosimilars Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Biosimilars Market
TABLE 4 Product Launches And Product Expansions– Biosimilars Market
TABLE 5 Acquisition and Mergers– Biosimilars Market
TABLE 6 Approvals and Trials – Biosimilars Market
TABLE 7 LAMEA Biosimilars Market by Application, 2018 - 2021, USD Million
TABLE 8 LAMEA Biosimilars Market by Application, 2022 - 2028, USD Million
TABLE 9 LAMEA Oncology Diseases Market by Country, 2018 - 2021, USD Million
TABLE 10 LAMEA Oncology Diseases Market by Country, 2022 - 2028, USD Million
TABLE 11 LAMEA Blood Disorders Market by Country, 2018 - 2021, USD Million
TABLE 12 LAMEA Blood Disorders Market by Country, 2022 - 2028, USD Million
TABLE 13 LAMEA Chronic & Autoimmune Diseases Market by Country, 2018 - 2021, USD Million
TABLE 14 LAMEA Chronic & Autoimmune Diseases Market by Country, 2022 - 2028, USD Million
TABLE 15 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 16 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 17 LAMEA Biosimilars Market by Type, 2018 - 2021, USD Million
TABLE 18 LAMEA Biosimilars Market by Type, 2022 - 2028, USD Million
TABLE 19 LAMEA Monoclonal Antibodies Market by Country, 2018 - 2021, USD Million
TABLE 20 LAMEA Monoclonal Antibodies Market by Country, 2022 - 2028, USD Million
TABLE 21 LAMEA Granulocyte-Colony Stimulating Factor Market by Country, 2018 - 2021, USD Million
TABLE 22 LAMEA Granulocyte-Colony Stimulating Factor Market by Country, 2022 - 2028, USD Million
TABLE 23 LAMEA Erythropoietin Market by Country, 2018 - 2021, USD Million
TABLE 24 LAMEA Erythropoietin Market by Country, 2022 - 2028, USD Million
TABLE 25 LAMEA Human Growth Hormone Market by Country, 2018 - 2021, USD Million
TABLE 26 LAMEA Human Growth Hormone Market by Country, 2022 - 2028, USD Million
TABLE 27 LAMEA Insulin Market by Country, 2018 - 2021, USD Million
TABLE 28 LAMEA Insulin Market by Country, 2022 - 2028, USD Million
TABLE 29 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 30 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 31 LAMEA Biosimilars Market by Country, 2018 - 2021, USD Million
TABLE 32 LAMEA Biosimilars Market by Country, 2022 - 2028, USD Million
TABLE 33 Brazil Biosimilars Market, 2018 - 2021, USD Million
TABLE 34 Brazil Biosimilars Market, 2022 - 2028, USD Million
TABLE 35 Brazil Biosimilars Market by Application, 2018 - 2021, USD Million
TABLE 36 Brazil Biosimilars Market by Application, 2022 - 2028, USD Million
TABLE 37 Brazil Biosimilars Market by Type, 2018 - 2021, USD Million
TABLE 38 Brazil Biosimilars Market by Type, 2022 - 2028, USD Million
TABLE 39 Argentina Biosimilars Market, 2018 - 2021, USD Million
TABLE 40 Argentina Biosimilars Market, 2022 - 2028, USD Million
TABLE 41 Argentina Biosimilars Market by Application, 2018 - 2021, USD Million
TABLE 42 Argentina Biosimilars Market by Application, 2022 - 2028, USD Million
TABLE 43 Argentina Biosimilars Market by Type, 2018 - 2021, USD Million
TABLE 44 Argentina Biosimilars Market by Type, 2022 - 2028, USD Million
TABLE 45 UAE Biosimilars Market, 2018 - 2021, USD Million
TABLE 46 UAE Biosimilars Market, 2022 - 2028, USD Million
TABLE 47 UAE Biosimilars Market by Application, 2018 - 2021, USD Million
TABLE 48 UAE Biosimilars Market by Application, 2022 - 2028, USD Million
TABLE 49 UAE Biosimilars Market by Type, 2018 - 2021, USD Million
TABLE 50 UAE Biosimilars Market by Type, 2022 - 2028, USD Million
TABLE 51 Saudi Arabia Biosimilars Market, 2018 - 2021, USD Million
TABLE 52 Saudi Arabia Biosimilars Market, 2022 - 2028, USD Million
TABLE 53 Saudi Arabia Biosimilars Market by Application, 2018 - 2021, USD Million
TABLE 54 Saudi Arabia Biosimilars Market by Application, 2022 - 2028, USD Million
TABLE 55 Saudi Arabia Biosimilars Market by Type, 2018 - 2021, USD Million
TABLE 56 Saudi Arabia Biosimilars Market by Type, 2022 - 2028, USD Million
TABLE 57 South Africa Biosimilars Market, 2018 - 2021, USD Million
TABLE 58 South Africa Biosimilars Market, 2022 - 2028, USD Million
TABLE 59 South Africa Biosimilars Market by Application, 2018 - 2021, USD Million
TABLE 60 South Africa Biosimilars Market by Application, 2022 - 2028, USD Million
TABLE 61 South Africa Biosimilars Market by Type, 2018 - 2021, USD Million
TABLE 62 South Africa Biosimilars Market by Type, 2022 - 2028, USD Million
TABLE 63 Nigeria Biosimilars Market, 2018 - 2021, USD Million
TABLE 64 Nigeria Biosimilars Market, 2022 - 2028, USD Million
TABLE 65 Nigeria Biosimilars Market by Application, 2018 - 2021, USD Million
TABLE 66 Nigeria Biosimilars Market by Application, 2022 - 2028, USD Million
TABLE 67 Nigeria Biosimilars Market by Type, 2018 - 2021, USD Million
TABLE 68 Nigeria Biosimilars Market by Type, 2022 - 2028, USD Million
TABLE 69 Rest of LAMEA Biosimilars Market, 2018 - 2021, USD Million
TABLE 70 Rest of LAMEA Biosimilars Market, 2022 - 2028, USD Million
TABLE 71 Rest of LAMEA Biosimilars Market by Application, 2018 - 2021, USD Million
TABLE 72 Rest of LAMEA Biosimilars Market by Application, 2022 - 2028, USD Million
TABLE 73 Rest of LAMEA Biosimilars Market by Type, 2018 - 2021, USD Million
TABLE 74 Rest of LAMEA Biosimilars Market by Type, 2022 - 2028, USD Million
TABLE 75 key information – Fresenius SE & Co. KGaA
TABLE 76 key information – Dr. Reddy’s Laboratories Ltd.
TABLE 77 Key Information – Pfizer, Inc.
TABLE 78 Key Information – Amgen, Inc.
TABLE 79 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 80 Key Information – Eli Lilly And Company
TABLE 81 KEY INFORMATION - MERCK & CO., INC.
TABLE 82 Key Information – Novartis AG
TABLE 83 Key Information – Biocon Limited
TABLE 84 Key Information – Intas Pharmaceutical Ltd.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Partnerships, Collaborations & Agreements : 2018, Jan – 2022, Aug) Leading Players
FIG 5 Recent strategies and developments: Fresenius SE & Co. KGaA
FIG 6 Recent strategies and developments: Dr. Reddy’s Laboratories Ltd.
FIG 7 Recent strategies and developments: Pfizer, Inc.
FIG 8 Recent strategies and developments: Amgen, Inc.
FIG 9 Recent strategies and developments: Teva Pharmaceuticals Industries Ltd.
FIG 10 Recent strategies and developments: Novartis AG
FIG 11 Recent strategies and developments: Biocon Limited
FIG 12 Recent strategies and developments: Intas Pharmaceutical Ltd.
Unique Offerings 